This test evaluates mutations in 7 important genes commonly associated with colorectal cancer. These mutations provide insights into tumor behavior, prognosis, and potential response to targeted therapies.
Patients diagnosed with colorectal cancer who are being evaluated for targeted therapy options.
Targets 7 clinically significant genes involved in colorectal cancer development and progression, and provides a targeted molecular profile.
